Cresco acted as lead counsel to Belgian health tech startup Cascador Health in its €3.4 million Series A round to further boost its data platform and European expansion. The round saw the participation of Qbic, Volta Ventures and Theodorus and Swiss healthcare provider Hirslanden.
The fresh capital will also enable the platform to scale its activities in Belgium and Switzerland. The funding comes on the back of its acquisition of Swiss company CORTS from Hirslanden to secure access to medical data by third parties.
Cresco has advised Cascador Health from its inception.
David Dessers, Elske Bleeker and Lukas Salden led the Cresco team that advised Cascador Health.
More information on this transaction can be found in Trends.
For any further information or questions, please contact David Dessers or Elske Bleeker.